Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer

JAMA Network Open

2025-05-01

(Press-News.org) About The Study: The findings of this study suggest a narrowing of racial and ethnic disparities in receipt of ERBB2 (formerly HER2 or HER2/neu)-targeted therapies over time among older Medicare beneficiaries with ERBB2-positive breast cancer. Future research is needed to understand the practices that contributed to the narrowing of racial and ethnic disparities and to develop implementation strategies to effectively improve the quality and equity of breast cancer care.

Corresponding Author: To contact the corresponding author, Utibe R. Essien, MD, MPH, email uessien@mednet.ucla.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.8086)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.8086?guestAccessKey=c0957767-f5eb-4d6d-88a4-15c747418b57&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050125

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Designer microbe shows promise for reducing mercury absorption from seafood

2025-05-01

Key takeaways · UCLA and UCSD scientists inserted DNA-encoding methylmercury detoxification enzymes into the genome of an abundant human gut bacterium. The engineered bacterium detoxified methylmercury in the gut of mice and dramatically reduced the amount that reached other tissues, such as the brain and liver. · Mice given an oral probiotic containing the engineered microbe and fed a diet high in bluefin tuna had much lower methylmercury levels than expected, suggesting that a probiotic might eventually make it safer for people to consume fish. · Researchers performed ...

Sex- and race-specific prevalence of hearing loss across the adult lifespan and associated factors

2025-05-01

About The Study: The prevalence and degree of hearing loss were highest among white male individuals and lowest among Black female individuals in this cohort study of 1,787 adults. Some factors associated with hearing loss, including noise exposure, differed across sex-specific and race-specific groups. Hearing loss is an important public health concern that could be addressed through tailored interventions to reduce its risk across populations. Corresponding Author: To contact the corresponding author, Lauren K. Dillard, PhD, AuD, email dillalau@musc.edu. To ...

Ptero firma: Footprints pinpoint when ancient flying reptiles conquered the ground

2025-05-01

Fossils of footprints over 160 million years old have helped palaeontologists at the University of Leicester to narrow down when pterosaurs adapted to live on the ground. These awe-inspiring flying reptiles of the Mesozoic era are often imagined soaring over the heads of dinosaurs. But new research shows that some of these ancient creatures were just as comfortable walking on the ground. In a groundbreaking new study published today in Current Biology (1 May), scientists at the University of Leicester have ...

New research from Mass General Brigham guides treatment regimen for aggressive blood cancer

2025-05-01

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas Relapsed/refractory (R/R) mature T and natural killer (NK)-cell lymphomas (TNKL) are aggressive blood cancers often resistant to frontline therapies. A team of Mass General Brigham researchers found that patients with these lymphomas had improved survival rates when treated with small molecule inhibitors as second-line therapy, followed by epigenetic modifiers as third-line therapy. Results of the study are published in the British Journal of Haematology. “Our robust ...

USC team develops a powerful new analytical tool to advance CAR T cell therapy research

2025-05-01

A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen receptor (CAR) T cells, including how they evolve during manufacturing and which ones are most effective at killing cancer. Using the platform, which leverages a laser-based technology known as spectral flow cytometry, researchers have already found one key insight: CAR T cells are better equipped to fight cancer after a shorter five-day expansion process than at the 10-day mark. The study was just published in the 25th anniversary special issue of Molecular Therapy, the flagship journal of the American Society of Gene & Cell Therapy. CAR ...

Boosting NAD+ levels slows aging in cells from Werner syndrome patients

2025-05-01

“Our results indicated compromised NAD+ metabolism in WS while NAD+ augmentation decreased senescence in both WS mesenchymal stem cells (MSCs) and primary fibroblasts, shedding light on potential therapeutics.” BUFFALO, NY — May 1, 2025 — A new research paper was published in Aging (Aging-US) on April 2, 2025, as the cover of Volume 17, Issue 4, titled “Decreased mitochondrial NAD+ in WRN deficient cells links to dysfunctional proliferation.” In this study, the team led by first author Sofie Lautrup ...

JMIR Rehabilitation and Assistive Technologies invites submissions on advancing telerehabilitation research and innovation

2025-05-01

(Toronto, May 1, 2025) JMIR Publications invites submissions to a new theme issue titled “The Importance of Telerehabilitation and Future Directions for the Field” in its open access journal JMIR Rehabilitation and Assistive Technologies. The premier, peer-reviewed journal is indexed in PubMed/PubMed Central, SCOPUS, DOAJ, Web of Science, Sherpa/Romeo and EBSCO/EBSCO Essentials. The field of telerehabilitation has rapidly evolved, demonstrating its effectiveness, feasibility, and safety across various medical conditions. As outlined ...

Seven stroke advocates recognized nationwide for resilience and community impact

2025-05-01

DALLAS, May 1, 2025 — Every 40 seconds someone in the U.S. has a stroke[1], one of the leading causes of serious, long-term disability. To spotlight the courage and dedication of those impacted by stroke, the American Stroke Association, a division of the American Heart Association, is honoring seven nationwide recipients through its annual Stroke Hero Awards. The awards celebrate stroke survivors, caregivers, health care professionals and advocates who are advancing awareness, education and support for the stroke community nationwide. ...

The National Multiple Sclerosis Society commits over $18 million for research to drive pathways to cures

2025-05-01

The National Multiple Sclerosis Society has committed $18.1 million in multi-year funding to support research projects aligned with its Pathways to Cures roadmap that focuses on three critical areas: stopping MS, restoring function and ending MS. The new projects include 16 research grants and 28 training fellowships and early career awards in the United States and internationally. The Society is committed to driving the best, most promising science and to training the next generation of pioneering MS researchers. More than 100 senior scientists from research institutions around the country, and a special committee ...

Virtual pulmonary rehabilitation programs are safe, effective for people with COPD

2025-05-01

Miami (May 1, 2025) – Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require supplemental oxygen, according to a new report. The report is published in the March 2025 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open-access journal. COPD is an inflammatory lung disease, comprising several conditions, including ...

Racial and ethnic disparities in receipt of ERBB2-targeted therapy for breast cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: